Cite
HARVARD Citation
Campiotti, L. et al. (2017). Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis. European journal of cancer. pp. 48-56. [Online].